Condition
    Moderate Evidence
    Effectiveness 3/5

    White Willow Bark for Joint Pain

    Standardized willow bark extract at 240 mg salicin daily beat placebo for chronic low back pain and shows modest benefit in osteoarthritis, with less gastric irritation than aspirin.

    Overview

    White willow bark is the botanical ancestor of aspirin. Its principal constituent, salicin, is converted in the body to salicylic acid — the same active molecule aspirin delivers, arrived at by a slower route. That lineage is the reason it works and also the reason its cautions read like a drug's rather than a herb's. For joint pain it is best understood as a mild, slow-onset analgesic rather than a disease-modifying agent. It reduces the pain signal; it does not repair cartilage.
    The clinical picture is genuinely mixed. Standardised extracts delivering 240 mg of salicin daily have beaten placebo in osteoarthritis and low back pain trials, but other well-conducted studies at the same dose found no benefit over placebo, and comparisons against standard NSAID doses generally favour the drug. Expect a modest effect, not a dramatic one.

    Verdict

    Likely effective

    Randomised placebo-controlled evidence supports a modest analgesic effect for standardised willow bark extract in osteoarthritis at 240 mg salicin daily, with good short-term tolerability. Results are inconsistent across trials and the effect is smaller than conventional NSAID doses.

    How It Works

    Salicin is hydrolysed by gut flora to saligenin, then oxidised in the liver to salicylic acid, which inhibits COX-1 and COX-2 and so reduces prostaglandin-driven inflammation and nociception. Because the conversion depends on gut and hepatic metabolism, onset is slower and peak plasma salicylate lower than with an equivalent aspirin dose.
    Willow bark is not salicin alone. The extract also carries polyphenols and flavonoids — notably catechins and procyanidins — that suppress TNF-alpha and NF-kB signalling independently of the salicylate pathway. Some researchers argue this explains why the whole extract outperforms what its measured salicin content alone would predict. Crucially, salicylic acid derived this way does not irreversibly acetylate platelet COX-1 the way aspirin does, so antiplatelet effects are weaker and shorter-lived.

    Dosing & Protocol

    Dose by salicin content. The trial standard is 240 mg of salicin daily; 120 mg daily has repeatedly failed to beat placebo, so half-strength products are unlikely to be worth taking. Take with food and allow one to two weeks of consistent use before judging.

    Evidence

    The linked randomised, placebo-controlled, double-blind trial in Phytotherapy Research tested a standardised willow bark extract in patients with osteoarthritis and reported a significant improvement in pain scores over placebo with good tolerability across the treatment period. That trial is the anchor for the verdict here, but it should be read alongside later studies that failed to replicate the effect at the same dose. The honest summary is a real but small and inconsistent analgesic benefit, best suited to people who want an NSAID-sparing option and accept a gentler effect.

    Only studies already linked to this pairing are shown.

    Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis: randomized placebo-controlled, double blind clinical trial

    Score: 7/10
    2001
    rct
    n=78

    Schmid B, Ludtke R, Selbmann HK +4 more

    WOMAC pain scores fell 14% with willow bark versus 2% with placebo.

    View source

    Safety

    Short-term tolerability in trials is good, with adverse event rates close to placebo and notably fewer gastrointestinal complaints than equivalent NSAID therapy. Reported effects are mild: stomach upset, nausea, occasional dizziness or rash. Long-term safety beyond a few months has not been formally characterised.

    Treat this as a salicylate, not a gentle herb

    Avoid entirely if you are allergic to aspirin or salicylates, have asthma that worsens with NSAIDs, or have active peptic ulcer disease or significant kidney impairment. Do not give to children or teenagers with a viral illness because of the theoretical Reye's syndrome risk. Avoid in pregnancy, particularly the third trimester, and stop before elective surgery.

    Interactions & Conflicts

    Because the active metabolite is salicylic acid, willow bark inherits aspirin's interaction profile in diluted form. The most important rule is not to stack it with other salicylates or NSAIDs on the assumption that a botanical adds nothing — it adds to the same total salicylate exposure.
    Interacts withSeverityMechanismAction
    major
    		—Do not combine routinely
    major
    		—Avoid unless supervised with INR monitoring
    major
    		—Avoid
    moderate
    		—Monitor blood pressure and renal function
    minor
    		—Limit intake while using

    References

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.